Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07788729 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07788729 · ClinicalTrials.gov record · last posted 2026-08-26

Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons

Study acronym: PRISMA
StatusRecruiting
PhaseNot applicable
Started2026-04-21
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Optimal patient-centered care is often not being delivered to cancer patients, especially to vulnerable populations like those living in underserved rural areas. This body of work will develop and pilot test a multicomponent intervention approach designed to improve the care and outcomes of cancer patients and their support persons (SPs) during and following their therapeutic journey. The intervention will involve the provision of social prescriptions and web-based micro-learning modules, as well as stepwise care based on ongoing monitoring of symptom burden and health. This project uses the strengths of innovative, individually tailored communication strategies and a comprehensive low-cost approach that are likely to support fair and equal patient access to optimal care beyond the funding period. By using a patient-driven approach in an interdisciplinary setting, it is anticipated that the intervention will improve the health outcomes of various patient populations, especially those living in rural areas. To achieve this, a methodologically robust mixed-methods approach and an effectiveness-implementation hybrid design will be employed to move effective strategies towards implementation into clinical practice. A number of standardized patient-reported outcome and experience measures will be used, including quality of life and knowledge of health and care. As a result of this research, an implementation toolbox will be developed that could be used by clinicians working in different healthcare settings and services, both nationally and internationally, to help provide highest quality cancer care.
Trial Details
NCT Number NCT07788729
Lead Sponsor University of Regensburg
Collaborators: Universitätsklinikum Köln, University Hospital Erlangen, Wuerzburg University Hospital, University Hospital Augsburg, University Hospital Regensburg, Charite University, Berlin, Germany
Conditions Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer, Malignant Melanoma
Enrollment 384 participants
Start Date 2026-04-21
Primary Completion 2028-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-26